Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.

European journal of human genetics : EJHG - 1 Oct 2015

Mastrokolias Anastasios, Ariyurek Yavuz, Goeman Jelle J, van Duijn Erik, Roos Raymund A C, van der Mast Roos C, van Ommen GertJan B, den Dunnen Johan T, 't Hoen Peter A C, van Roon-Mom Willeke M C

Abstract excerpt

With several therapeutic approaches in development for Huntington's disease, there is a need for easily accessible biomarkers to monitor disease progression and therapy response. We performed next-generation sequencing-based transcriptome analysis of total RNA from peripheral blood of 91 mutation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to High-Throughput Nucleotide Sequencing

Share to Huntington Disease

Share to MicroRNAs

Share to Transcriptome

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 25626709
DOI: 10.1038/ejhg.2014.281
PMCID: PMC4592077

Genes

ANXA3
AQP9
CYSTM1
PROK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25626709-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.PMID 25626709Read ↗

Whole blood transcriptome profile identifies motor neurone disease (MND) RNA biomarker signaturesSemantic proximity Read ↗

Whole blood transcriptome profile identifies motor neurone disease RNA biomarker signaturesSemantic proximity Read ↗

Abnormal molecular signatures of inflammation, energy metabolism and vesicle biology in human Huntington disease peripheral tissuesSemantic proximity Read ↗

Proteomic profiling of baseline CSF and serum from HDClarity identifies signatures for Huntington disease staging and stratificationSemantic proximity Read ↗

Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissuesSemantic proximity Read ↗

Circulating transcriptional biomarkers serve as surrogates of disease progression in Charcot-Marie-Tooth 1A diseaseSemantic proximity Read ↗

Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease.Semantic proximity Read ↗

Common disease signatures from gene expression analysis in Huntington’s disease human blood and brainSemantic proximity Read ↗

Sporadic hereditary motor and sensory neuropathies: Advances in the diagnosis using next generation sequencing technology.Semantic proximity Read ↗

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association studySemantic proximity Read ↗

A Decade of Discovery of Huntington's Disease Biomarkers: A Comprehensive Review of its Established and Emerging Bi-omarkersSemantic proximity Read ↗

A meta-analysis of transcriptomic profiles from Huntington’s disease patients points to a pathophysiological role of CDC42, NFY, DLX1 and PRMT3Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.